IC 303

 "Hype, Promise, and Reality: Orthopedic Use of Biologics in 2023"  

Course Description:

This ICL will cover the most recent updates regarding the uses of orthobiologics in the management of orthopedic patients.  Covered will be regulatory aspects of orthobiologics, basic science and clinical evidence in the treatment of osteoarthritis and soft tissue restoration, and strategies for billing in the use of orthobiologics.  The presentations are as follows:

• Biologics for the treatment of osteoarthritis
• Orthobiologics in Soft tissue Restoration
• Regulatory Perspectives in Orthobiologics
• Billing in the Use of Orthobiologics

Learning Objectives:

• At the conclusion of this ICL, the participant will understand the regulatory aspects of the use of orthobiologics
• At the conclusion of this ICL, the participant will understand the basic science and clinical research supporting orthobiologics in cartilage and soft tissue healing
• At the conclusion of this ICL, the participant will understand how to bill for orthobiologics treatments legally and ethically

Faculty:

Stephen C. Weber, MD

Jason L. Dragoo, MD

Louis F. McIntyre, MD

Scott A. Rodeo, MD